Components from spider venom activate macrophages against glioblastoma cells: new potential adjuvants for anticancer immunotherapy

J Biochem. 2021 Sep 22;170(1):51-68. doi: 10.1093/jb/mvab020.

Abstract

Immunomodulation has been considered an important approach in the treatment of malignant tumours. However, the modulation of innate immune cells remains an underexplored tool. Studies from our group demonstrated that the Phoneutria nigriventer spider venom (PnV) administration increased the infiltration of macrophage in glioblastoma, in addition to decreasing the tumour size in a preclinical model. The hypothesis that PnV would be modulating the innate immune system led us to the main objective of the present study: to elucidate the effects of PnV and its purified fractions on cultured macrophages. Results showed that PnV and the three fractions activated macrophages differentiated from bone marrow precursors. Further purification generated 23 subfractions named low weight (LW-1 to LW-12) and high weight (HW-1 to HW-11). LW-9 presented the best immunomodulatory effect. Treated cells were more phagocytic, migrated more, showed an activated morphological profile and induced an increased cytotoxic effect of macrophages on tumour cells. However, while M1-controls (LPS) increased IL-10, TNF-alpha and IL-6 release, PnV, fractions and subfractions did not alter any cytokine, with the exception of LW-9 that stimulated IL-10 production. These findings suggest that molecules present in LW-9 have the potential to be used as immunoadjuvants in the treatment of cancer.

Keywords: Phoneutria nigriventer; glioma; immunomodulation; innate immune system; phagocytosis.

MeSH terms

  • Adjuvants, Immunologic / pharmacology*
  • Animals
  • Cells, Cultured
  • Glioblastoma / metabolism
  • Glioblastoma / pathology
  • Glioblastoma / therapy*
  • Humans
  • Immunotherapy*
  • Macrophages / drug effects*
  • Mice
  • Spider Venoms / pharmacology*

Substances

  • Adjuvants, Immunologic
  • Spider Venoms